K182874 is an FDA 510(k) clearance for the Fenom Pro Nitric Oxide Test. Classified as System, Test, Breath Nitric Oxide (product code MXA), Class II - Special Controls.
Submitted by Spirosure, Inc. (Pleasanton, US). The FDA issued a Cleared decision on February 13, 2019 after a review of 124 days - within the typical 510(k) review window.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3080 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.